Editorial About: “A Prospective, Open-Label, Multicenter Phase II Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma”

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2019-12, Vol.26 (13), p.4175-4177
Main Authors: Schwartz, Patrick B., Uboha, Nataliya V., Weber, Sharon M.
Format: Article
Language:English
Subjects:
Adenocarcinoma
Deoxycytidine - analogs & derivatives
Gemcitabine
Humans
Medicine
Medicine & Public Health
Neoadjuvant Therapy
Oncology
Pancreas
Pancreatic cancer
Pancreatic Neoplasms
Pancreatic Tumors
Prospective Studies
Surgery
Surgical Oncology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-019-07737-6